Can Gut-Brain Reset Help Manage Long COVID and ME/CFS Symptoms?

To understand how a probiotic supplement can influence neurological symptoms like brain fog and anxiety, we first need to explore the natural function of the microbiota-gut-brain (MGB) axis. In a healthy human body, the gastrointestinal tract is home to trillions of microorganisms, collectively known as the gut microbiome. These bacteria are not merely passive passengers; they are active participants in our physiology. The MGB axis is a complex, bidirectional communication network that links the enteric nervous system (the "second brain" located in the gut) with the central nervous system (the brain and spinal cord). This communication occurs through three primary pathways: neural, endocrine (hormonal), and immunological.

The neural pathway is heavily dependent on the vagus nerve, a massive cranial nerve that acts as a biological superhighway between the gut and the brain. Remarkably, about 80% to 90% of the nerve fibers in the vagus nerve send signals from the gut to the brain, rather than the other way around. Beneficial gut bacteria produce metabolites, such as short-chain fatty acids (SCFAs) like butyrate, acetate, and propionate, which directly stimulate the vagus nerve. These signals travel up to the brainstem and influence areas of the brain responsible for emotional regulation, stress response, and cognitive function. When the microbiome is healthy and diverse, this continuous stream of communication helps maintain a state of neurological calm and metabolic homeostasis.

The concept of the gut-brain connection has given rise to a fascinating new category of therapeutic interventions known as "psychobiotics." A psychobiotic is defined as a live microorganism that, when ingested in adequate amounts, confers a mental health or neurological benefit to the host. Unlike standard, broad-spectrum probiotics that are primarily designed to support general digestion, psychobiotics are highly specific strains of bacteria that have been clinically proven to produce neuroactive substances. These beneficial microbes can synthesize or influence the production of critical neurotransmitters, including serotonin, dopamine, and gamma-aminobutyric acid (GABA).

For example, it is a well-established physiological fact that approximately 90% of the body's serotonin—a neurotransmitter essential for mood regulation, sleep cycles, and gut motility—is produced in the gastrointestinal tract. Psychobiotic strains actively participate in the metabolic pathways that create these neurotransmitters. By modulating the gut environment, psychobiotics can help lower systemic inflammation, which in turn prevents the brain's immune cells (microglia) from becoming hyperactive. This targeted approach makes psychobiotics an invaluable tool for patients dealing with the neuroinflammatory aspects of conditions like Long COVID and ME/CFS.

Gut-Brain Reset is a specialized psychobiotic formula powered by two proprietary, heavily researched bacterial strains: Bifidobacterium longum 1714 and Bifidobacterium longum 35624. Both of these strains belong to the Bifidobacterium genus, which are keystone, endogenous bacteria naturally found in a healthy human gut from infancy. However, despite sharing a species name, these two specific strains have distinctly different, yet highly complementary, mechanisms of action at the cellular level.

Bifidobacterium longum 1714 has gained international scientific recognition for its potent ability to modulate brain wave activity, blunt the physiological stress response, and support cognitive function. It acts primarily on the neuroendocrine pathways of the gut-brain axis. Conversely, Bifidobacterium longum 35624 is one of the most rigorously tested strains in the world for gastrointestinal health, specifically targeting the underlying mucosal inflammation and barrier dysfunction that drive conditions like Irritable Bowel Syndrome (IBS). Together, they provide a comprehensive, dual-action approach to restoring the precise pathways that are often devastated by chronic, infection-associated illnesses.

To understand why supplements like Gut-Brain Reset are so relevant for chronic illness, we must examine how conditions like Long COVID and ME/CFS alter the body's internal ecosystems. When a person is infected with a virus like SARS-CoV-2, the immune system mounts a massive inflammatory response. Recent research indicates that this acute infection, and the subsequent chronic inflammatory state, severely disrupts the gut microbiome—a condition known as gut dysbiosis. You can learn more about the initial triggers of these conditions in our detailed guide on What Causes Long COVID?.

In patients with Long COVID and ME/CFS, clinical studies consistently show a marked depletion of beneficial, anti-inflammatory bacteria, particularly Bifidobacterium species. These keystone bacteria are responsible for fermenting dietary fibers into short-chain fatty acids (SCFAs). When Bifidobacterium populations collapse, SCFA production plummets. This is a critical loss because SCFAs are the primary energy source for the cells lining the colon (colonocytes). Without adequate SCFAs, the gut environment becomes hostile, allowing opportunistic, pro-inflammatory pathogens to overgrow and dominate the microbiome, creating a vicious cycle of localized gut inflammation.

The depletion of SCFAs and the rise of localized gut inflammation lead directly to a breakdown of the intestinal mucosal barrier, commonly referred to as "leaky gut." The lining of the intestines is only one cell thick, held together by complex protein structures called tight junctions (including claudins and occludins). Chronic inflammation causes these tight junctions to loosen. When the barrier is compromised, bacterial endotoxins—most notably lipopolysaccharides (LPS) from the cell walls of pathogenic bacteria—leak out of the gut and translocate into the systemic bloodstream.

Once LPS enters the bloodstream, it triggers a massive, systemic immune response. The immune system recognizes these endotoxins as foreign invaders and releases a flood of pro-inflammatory cytokines, such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha). These inflammatory molecules can cross the blood-brain barrier, activating the brain's resident immune cells (microglia) and causing profound neuroinflammation. This neuroinflammatory cascade is a primary driver of the severe cognitive dysfunction, brain fog, and mood instability experienced by patients. We explore these specific GI manifestations further in our article on Gastrointestinal Symptoms Seen with Long COVID.

The pathophysiology of Long COVID and ME/CFS also heavily involves the autonomic nervous system, leading to conditions like dysautonomia and Postural Orthostatic Tachycardia Syndrome (POTS). The vagus nerve, which controls parasympathetic (rest and digest) functions, is highly vulnerable to the systemic inflammation originating from the gut. When the vagus nerve is inflamed or impaired by viral persistence, it loses its ability to regulate heart rate, blood pressure, and gut motility.

This impairment creates a devastating feedback loop. Poor vagal tone leads to sluggish digestion (gastroparesis) or erratic bowel movements, which further exacerbates gut dysbiosis. Simultaneously, the brain loses its primary mechanism for receiving calming, anti-inflammatory signals from the gut. The body becomes trapped in a state of sympathetic dominance—a chronic "fight or flight" mode. This constant physiological stress drains cellular energy reserves, contributing heavily to the debilitating fatigue and post-exertional malaise (PEM) that define these illnesses. Understanding this complex web of symptoms is crucial, as discussed in our overview of How Does a Doctor Diagnose Long COVID?.

Supplementing with the specific psychobiotic strains in Gut-Brain Reset offers a targeted way to interrupt the vicious cycles of dysbiosis and neuroinflammation. Bifidobacterium longum 1714 operates primarily by modulating the Hypothalamic-Pituitary-Adrenal (HPA) axis, the body's central stress response system. In patients with chronic illness, the HPA axis is often dysregulated, leading to erratic cortisol levels that exacerbate fatigue, anxiety, and sleep disturbances.

At the cellular level, B. longum 1714 has been shown to physically blunt the secretion of cortisol in response to acute stressors. According to landmark clinical research, this strain interacts with the enteric nervous system to send inhibitory signals up the vagus nerve to the hypothalamus. This signaling downregulates the release of Corticotropin-Releasing Hormone (CRH), which in turn reduces the downstream production of cortisol by the adrenal glands. By buffering the HPA axis, B. longum 1714 helps protect the brain—specifically the hippocampus, which is highly sensitive to cortisol toxicity—from the damaging effects of chronic physiological stress, thereby supporting memory and cognitive function.

One of the most profound mechanisms of B. longum 1714 involves its influence on tryptophan metabolism. Tryptophan is an essential amino acid that serves as the precursor to serotonin. However, in states of chronic inflammation and immune activation (such as Long COVID), pro-inflammatory cytokines upregulate an enzyme called indoleamine 2,3-dioxygenase (IDO). The IDO enzyme essentially "steals" tryptophan, shunting it away from the serotonin-producing pathway and forcing it down the kynurenine pathway. This pathway produces neurotoxic metabolites like quinolinic acid, which overstimulate NMDA receptors in the brain, causing anxiety, depression, and severe brain fog.

B. longum 1714 helps reverse this neurotoxic shunt. By producing specific anti-inflammatory metabolites, this psychobiotic downregulates the activity of the IDO enzyme. Furthermore, recent mechanistic studies have revealed that B. longum 1714 directly produces bioavailable tryptophan and indole lactic acid (ILA) within the gut lumen. By reducing inflammation and supplying the necessary precursors, the strain successfully redirects metabolism back toward the neuroprotective pathway, ensuring a robust synthesis of serotonin. This increase in serotonin not only stabilizes mood and anxiety but also regulates gut motility, helping to resolve unpredictable bowel habits.

While 1714 focuses on the neuroendocrine aspects of the gut-brain axis, Bifidobacterium longum 35624 acts as a structural and immunological repair agent for the gastrointestinal tract. This strain has a unique affinity for the human colonic mucosa. When ingested, it navigates through the digestive tract and binds directly to the inflamed epithelial cells of the gut lining. Once attached, it exerts a powerful localized healing effect on the compromised intestinal barrier.

At a molecular level, B. longum 35624 upregulates the expression of specific tight junction proteins, such as claudin-1 and occludin. By reinforcing these cellular "zippers," the probiotic effectively seals the leaky gut, halting the translocation of lipopolysaccharides (LPS) into the bloodstream. This direct action cuts off the primary source of systemic endotoxemia, significantly reducing the systemic inflammatory burden that drives symptoms in ME/CFS and Long COVID.

Beyond structural repair, B. longum 35624 is a potent immunomodulator. Patients with chronic gastrointestinal distress often suffer from visceral hypersensitivity—a condition where the nerves in the gut wall become overly sensitive to normal amounts of gas or stool, resulting in severe bloating and abdominal pain. This hypersensitivity is driven by low-grade mucosal inflammation.

Clinical trials have demonstrated that B. longum 35624 interacts with dendritic cells in the gut-associated lymphoid tissue (GALT) to induce the production of Regulatory T-cells (Tregs). These Tregs secrete high levels of Interleukin-10 (IL-10), a powerful anti-inflammatory cytokine, while simultaneously suppressing the production of pro-inflammatory Interleukin-12 (IL-12). By normalizing the IL-10 to IL-12 ratio, the strain calms the localized immune response, dramatically reducing visceral hypersensitivity and alleviating the core symptoms of bloating, gas, and abdominal discomfort.

By targeting the gut-brain axis and reducing neuroinflammation, the psychobiotic strains in Gut-Brain Reset may help manage several debilitating neurological symptoms associated with chronic complex illnesses:

Simultaneously, the targeted action of B. longum 35624 on the intestinal mucosa provides relief for a variety of physical and gastrointestinal symptoms. You can read more about how these systemic issues are interconnected in our post, Can Long COVID Trigger ME/CFS? Unraveling the Connection.

One of the most significant challenges with probiotic supplementation is ensuring that the live bacteria survive the harsh, highly acidic environment of the stomach to reach the lower intestines where they exert their benefits. The strains in Gut-Brain Reset possess a unique evolutionary advantage that ensures high bioavailability. Both B. longum 1714 and B. longum 35624 have the genetic capability to produce an Exopolysaccharide (EPS) coating.

This EPS layer acts as a microscopic, protective shield made of complex sugars. It encapsulates the bacteria, allowing them to safely transit through gastric acid and bile salts. Once the bacteria reach the colon, the EPS coating serves a second critical function: it acts as an adherence factor, allowing the probiotics to bind tightly to the intestinal mucosa rather than simply passing through the digestive tract. Furthermore, the EPS itself interacts with the host's immune cells, contributing to the immunomodulatory and anti-inflammatory effects observed in clinical trials.

Gut-Brain Reset provides a potent dose of 10 Billion CFU (Colony Forming Units) of beneficial bacteria per serving. This dosage is carefully calibrated based on clinical efficacy data, ensuring that a sufficient number of viable organisms colonize the gut to enact measurable physiological changes. The suggested use is to take 2 capsules per day.

For optimal absorption and survival of the bacteria, it is generally recommended to take the capsules with food. The presence of food helps buffer stomach acid, creating a more hospitable environment for the probiotics during their transit. It is important to set realistic expectations regarding the timeline for symptom relief. While some individuals may notice improvements in digestive comfort within the first two weeks, the neurological and mood-stabilizing benefits of psychobiotics typically require 4 to 8 weeks of consistent, daily supplementation to reach full efficacy, as the gut microbiome takes time to rebalance and alter neurotransmitter production.

Because Gut-Brain Reset contains live bacterial strains, there are specific practical considerations regarding its use alongside other medications. The most critical interaction is with oral antibiotics. Antibiotics cannot distinguish between pathogenic bacteria and beneficial probiotics; they will eradicate both. If you are prescribed a course of antibiotics, you must space out your probiotic dose. It is universally recommended to take Gut-Brain Reset at least 2 to 3 hours before or after administering an antibiotic to ensure the survival of the psychobiotic strains.

Additionally, individuals who are severely immunocompromised or who are taking heavy immunosuppressant medications (such as those used for organ transplants) should exercise caution and consult their healthcare provider before introducing live bacteria into their system, due to a theoretical risk of bacterial translocation. For more information on managing complex medication regimens, see our guide on What Drugs Are Used for COVID Long Haulers?.

The efficacy of the strains within Gut-Brain Reset is backed by robust, gold-standard clinical trials. Bifidobacterium longum 1714, in particular, has been the subject of groundbreaking research in the field of psychobiotics. In a landmark 2016 study published in Translational Psychiatry by the APC Microbiome Institute, researchers evaluated healthy volunteers subjected to the Socially Evaluated Cold Pressor Test—an acute physical and psychological stressor. The participants who received 1 billion CFU of B. longum 1714 daily for four weeks demonstrated a significantly blunted release of salivary cortisol compared to the placebo group. Furthermore, electroencephalography (EEG) testing revealed altered brain wave activity that correlated with improved memory processing and sustained attention.

A subsequent 2019 study published in the American Journal of Gastroenterology utilized Magnetoencephalography (MEG) to observe real-time brain activity in adults exposed to social stress via a computerized exclusion game. The researchers found that B. longum 1714 actively modulated the neural responses in brain regions responsible for emotional regulation. Participants in the probiotic group reported significantly reduced feelings of distress and mental fatigue, alongside an increase in perceived vitality, proving that this specific strain can physically alter how the brain processes emotional and social stress.

Similarly, Bifidobacterium longum 35624 is supported by decades of rigorous gastroenterological research. A foundational randomized, double-blind, placebo-controlled trial involving over 360 patients with Irritable Bowel Syndrome demonstrated that specific dosages of B. longum 35624 resulted in a remarkable 38% reduction in abdominal pain. The strain significantly improved composite IBS scores, with marked reductions in bloating, bowel dysfunction, and straining compared to the placebo.

More recently, a 2023 real-world observational study evaluated adults with Rome IV-diagnosed IBS taking the strain over an 8-week period. The results were striking: patients experienced a 43.4% reduction in their Total IBS Symptom Score. The mean symptom grades for bloating and the passage of gas fell significantly from "moderate" at baseline to "very mild to mild." Post-hoc analysis revealed that bloating and diarrhea scores had already significantly improved by week 2, highlighting the rapid, localized healing effect of this strain on the intestinal mucosa.

The application of targeted microbiome therapies for infection-associated chronic illnesses is rapidly expanding. A highly significant 2023 randomized controlled trial known as the SIM01 study, conducted in Hong Kong and published in The Lancet Infectious Diseases, evaluated 463 patients with Long COVID. Patients receiving a synbiotic formulation containing anaerobic Bifidobacterium strains for six months showed significantly higher improvement rates across multiple neurological and physical symptoms compared to a placebo. Specifically, the probiotic group was more than twice as likely to see improvements in fatigue, memory loss, difficulty concentrating, and gastrointestinal upset, strongly validating the use of targeted Bifidobacterium therapies for managing the complex sequelae of viral infections.

Living with conditions like Long COVID, ME/CFS, and dysautonomia is an incredibly challenging journey. The invisible nature of these illnesses—where you look fine on the outside but are battling severe neurological and physical dysfunction on the inside—can be profoundly isolating. It is important to know that your symptoms are real, they are rooted in complex physiological disruptions like gut dysbiosis and neuroinflammation, and you are not alone in this fight. We understand the daily toll this takes, as discussed in our supportive guide on How Can You Live with Long-Term COVID.

While the science behind psychobiotics is highly promising, it is crucial to remember that no single supplement is a cure-all for complex chronic illnesses. Gut-Brain Reset is designed to be a powerful tool within a broader, comprehensive management strategy. Healing the gut-brain axis requires a multi-faceted approach that includes aggressive pacing to manage post-exertional malaise, dietary modifications to support microbiome diversity, nervous system regulation techniques, and ongoing medical care. For many, navigating these illnesses also involves understanding legal and occupational protections, which we cover in Is Long COVID Considered a Disability?.

By addressing the foundational health of your microbiome, you can help lower systemic inflammation, support your body's natural neurotransmitter production, and improve your overall quality of life. Always consult with your healthcare provider before starting any new supplement regimen to ensure it aligns with your specific medical needs and current treatment plan.